__NUXT_JSONP__("/drugs/MUC1-targeted_Peptide_GO-203-2C", (function(a,b,c,d){return {data:[{drug:{slug:b,emaEpar:[],fdaDrugLabel:[],id:b,nciThesaurus:{casRegistry:a,chebiId:a,chemicalFormula:a,definition:"An optimized small peptide drug candidate targeting epithelial mucin (MUC1) with antineoplastic activity. MUC1-targeted peptide GO-203-2C interacts with oncoprotein MUC1 C-terminal subunit on the cell surface, thereby impeding cell-cell interactions, signaling, and metastasis. MUC1 antigen, a membrane bound glycoprotein expressed by most glandular and ductal epithelial cells, is over-expressed in many diverse human carcinomas including those of the breast, prostate, lung, colon, pancreas, and ovary, and has been associated with poor prognosis.",fdaUniiCode:"5YSY733NA3",identifier:"C95722",preferredName:c,semanticType:"Amino Acid, Peptide, or Protein",subclassOf:["C1752"],synonyms:["GO-203-2C",c]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FMUC1-targeted_Peptide_GO-203-2C",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("","MUC1-targeted_Peptide_GO-203-2C","MUC1-targeted Peptide GO-203-2C","2021-10-30T13:48:05.973Z")));